Overall Revision Summary - The company has revised its Articles of Association to enhance governance structure and compliance with the updated Company Law and relevant regulations [1][2] - The company will abolish the supervisory board and its rules, transferring its responsibilities to the Audit and Risk Control Committee of the board [2][3] Key Amendments to Articles of Association - The term "Shareholders' Meeting" has been standardized to "Shareholders' Assembly," and new sections regarding controlling shareholders, independent directors, and board committees have been added [2][3] - The company will no longer have a supervisory board, and the current supervisors will cease their roles, with the Audit and Risk Control Committee assuming the supervisory functions [2][3] - The revised Articles emphasize the importance of legal compliance and governance, aligning with the principles of the Communist Party of China [4][5] Governance and Management Structure - The Articles outline the responsibilities of the board of directors as the legal representatives of the company, including the appointment of a new legal representative within 30 days if the current one resigns [3][4] - The company aims to strengthen its legal governance and compliance management, ensuring the protection of the rights of shareholders and creditors [4][5] Company Mission and Values - The company’s mission is to enhance the quality of life through technological advancement and integrity, focusing on high-quality development and maximizing shareholder value [6][7] - The company is committed to becoming a trusted global provider of pharmaceutical and medical device services, contributing to national health initiatives and the Belt and Road Initiative [6][7] Shareholder Rights and Responsibilities - Shareholders have the right to receive dividends and participate in decision-making processes, including the right to request meetings and propose agenda items [12][13] - The company emphasizes the obligation of shareholders to comply with laws and regulations, ensuring responsible exercise of their rights [18][19] Financial and Operational Governance - The company will implement strict regulations regarding external guarantees, requiring shareholder approval for guarantees exceeding certain thresholds [25][26] - The Articles stipulate that the company must maintain transparency in its financial dealings and adhere to regulatory requirements for information disclosure [26][27]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 中科微至科技股份有限公司（以下简称"公司"）于 2025 年 8 月 8 日召开第 二届董事会第二十五次会议审议通过了《关于修订 <中科微至科技股份有限公司> 章程>、新增及修订公司部分治理制度的议案》、《关于增选第二届董事会非独 立董事的议案》，现将有关情况公告如下： 一、本次增加董事会人数的情况说明 二、增选第二届董事会非独立董事的情况说明 证券代码：688211 证券简称：中科微至 公告编号：2025-036 中科微至科技股份有限公司 关于增选第二届董事会非独立董事的公告 根据《中华人民共和国公司法》（以下简称"《公司法》"）《上市公司章程 指引》等法律法规、规范性文件的规定，结合公司实际情况，为进一步完善公司 治理结构，切实保障公司长期战略规划的有效实施，公司拟修订《中科微至科技 股份有限公司章程》，将董事会成员由 7 名增至 9 名，新增一名非独立董事，一 名职工代表董事，独立董事保持 3 名不变。职工代表董事由职工代表大会选举产 生。 附件：非独立董事候选人简历 ...

杭叉集团股东大会会议资料 杭叉集团股份有限公司 会议资料 中国·杭州 二○二五年八月 杭叉集团股东大会会议资料 议案三： 关于公司增加为客户提供融资租赁业务回购担保额度的议案 ........ 79 杭叉集团股东大会会议资料 会议议程 一、会议时间 现场会议：2025 年 8 月 13 日（星期三）14:00 网络投票：2025 年 8 月 13 日（星期三）采用上海证券交易所网络投票系统，通过 交易系统投票平台的投票时间为股东大会召开当日的交易时间段，即 9:15-9:25， 二、现场会议地点 浙江省杭州市临安区相府路 666 号公司办公楼一楼 8 号会议室 三、会议主持人 杭叉集团股份有限公司董事长赵礼敏先生 四、会议审议事项 五、会议流程 (一) 会议开始 (二) 宣读议案 (三) 审议议案并投票表决 占公司有表决权股份总数的比例 杭叉集团股东大会会议资料 事及相关与会人员在股东大会会议记录上签字 (四) 会议决议 (五) 会议主持人宣布闭会 杭叉集团股东大会会议资料 会议须知 为了维护杭叉集团股份有限公司（以下简称"公司"或"杭叉集团"）全体股 东的合法权益，确保股东大会的正常秩序和议事效率，保证大会 ...

证券代码：688018 证券简称：乐鑫科技 公告编号：2025-057 本议案尚需提交股东大会审议。 第三届监事会第七次会议决议公告 本公司及监事会全体成员保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 （一）审议通过《关于取消监事会、变更公司注册地址、修订公司章程及 部分管理制度的议案》 经审议，监事会认为本次公司拟取消监事会、变更公司注册地址、修订公司 章程及部分管理制度的事项系公司为全面贯彻落实最新法律、法规及规范性文件 要求，结合公司实际情况和业务发展需要做出的决定，有利于进一步完善公司治 理结构、更好地满足公司经营发展需求。该事项符合《公司法》《上市公司章程 指引》等法律、法规及规范性文件的规定，不存在损害股东特别是中小股东利益 的情形。监事会取消后，公司监事及监事会主席随之取消、《监事会议事规则》 等监事会相关制度相应废止，并由董事会审计委员会承接《公司法》规定的监事 会职权。在公司股东大会审议通过取消监事会事项前，公司监事会仍将严格按照 法律、法规及规范性文件的要求继续履行监事会职责。 乐鑫信息科技（上海） ...

Core Viewpoint - Shenzhen Beiqing Technology Co., Ltd. has identified non-operational fund occupation issues involving its actual controller, Ma Xuejun, and has implemented corrective measures to prevent recurrence [1][3][5]. Group 1: Non-operational Fund Occupation - The company discovered that its actual controller had occupied funds through employee loans and advance payments to suppliers, totaling 4.0823 million yuan (approximately 0.408 million) [1][2]. - Specific instances include 1.15 million yuan and 2.9323 million yuan occupied through employee loans, and 3 million yuan and 5 million yuan paid in advance to suppliers, totaling 8 million yuan [2]. Group 2: Rectification Measures - The company has established internal management systems to address the fund occupation issues, focusing on improving employee loan management and prepayment processes [3][4]. - Training sessions have been organized to enhance compliance awareness among management and staff regarding relevant laws and regulations [5]. Group 3: Company Apology and Commitment - The company and its management have acknowledged the seriousness of the situation and have issued a sincere apology to investors, committing to learn from the incident and prevent future occurrences [5][6]. Group 4: Governance Changes - The company has decided to abolish the supervisory board and transfer its responsibilities to the audit committee of the board of directors to enhance governance structure [7][8][10]. - The decision was made during the sixth supervisory board meeting, which was conducted in accordance with legal regulations [9]. Group 5: Fund Usage Planning - The supervisory board approved a plan for the use of surplus funds from the information technology upgrade project, ensuring compliance with relevant regulations and benefiting the company's product development [11][13]. Group 6: Organizational Restructuring - The company has adjusted its organizational structure to align with its strategic goals and operational needs, which is not expected to significantly impact its business activities [15].

Group 1 - The company has decided to abolish the supervisory board and transfer its responsibilities to the audit committee of the board of directors, in accordance with the latest amendments to the Company Law of the People's Republic of China [1][2][5] - The company will revise its Articles of Association and related meeting rules, including renaming the "Rules for Shareholders' Meeting" to "Rules for Shareholder Meetings" [2][5] - The resolution to abolish the supervisory board and amend the Articles of Association was passed unanimously by the board of directors [5][7] Group 2 - The company will hold its first extraordinary general meeting of 2025 on August 20, 2025, at 11:00 AM, where the proposed changes will be submitted for shareholder approval [17][18] - The voting for the extraordinary general meeting will be conducted through a combination of on-site and online voting [18][19] - The company will also change its registered address from "993 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan" to "1059 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan" due to a reassignment of the office location by the local police station [33][34]

Core Viewpoint - Shanghai Kaisa Biotechnology Co., Ltd. has decided to abolish its supervisory board and amend its articles of association, with the audit committee of the board taking over the supervisory functions [1][2]. Summary by Sections Cancellation of Supervisory Board - The company will no longer have a supervisory board, as per the relevant laws and regulations, with the audit committee of the board assuming the supervisory responsibilities [2][3]. - The existing rules regarding the supervisory board will be abolished, and the company will continue to ensure compliance and oversight until the shareholders' meeting approves this change [2]. Amendments to Articles of Association - The amendments aim to enhance the corporate governance structure in line with the requirements for companies listed on the Sci-Tech Innovation Board [3]. - Specific changes include the redefinition of the roles and responsibilities of the board and the legal representative [4][5]. - The articles will now reflect that the legal representative is the chairman of the board, and the company will bear civil liability for actions taken by the legal representative [4][5]. Shareholder Rights and Responsibilities - Shareholders will continue to have rights to dividends and other benefits proportional to their shareholdings [12][13]. - The articles stipulate that shareholders must comply with laws and the company's regulations, and they cannot abuse their rights to harm the company or other shareholders [39][40]. Financial Assistance and Guarantees - The company must seek approval from the shareholders' meeting for any financial assistance or guarantees exceeding certain thresholds, ensuring transparency and accountability [20][21]. - Specific conditions under which the company can provide financial assistance or guarantees are outlined, including limits based on the company's audited net assets [20][21].

根据《公司法》等相关法律法规、规范性文件的规定，为进一步完善公司治 理结构，提高董事会决策的科学性、有效性，结合公司实际情况，公司拟将董事 会成员由 7 名增至 9 名，增加的两名董事为一名非独立董事、一名职工代表董事 （由公司职工代表大会选举产生），独立董事人数保持 3 名不变，符合《上市公 司独立董事管理办法》中独立董事占董事会成员的比例的要求。 证券代码：300709 证券简称：精研科技 公告编号：2025-046 江苏精研科技股份有限公司 关于增加董事会席位、修订《公司章程》 并授权办理工商变更（备案）登记事项的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 江苏精研科技股份有限公司（以下简称"公司"）于 2025 年 8 月 1 日召开 第四届董事会第八次会议，审议通过了《关于增加董事会席位、修订 <公司章程> 并授权办理工商变更（备案）登记事项的议案》，现就有关事项公告如下： 一、增加董事会席位 二、《江苏精研科技股份有限公司章程》修订情况 根据《公司法》、《证券法》、《上市公司章程指引》、《深圳证券交易所 创业板股票上市规则》、《深圳证券交 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688146 证券简称：中船特气 公告编号：2025-039 中船（邯郸）派瑞特种气体股份有限公司 第二届监事会第五次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 中船（邯郸）派瑞特种气体股份有限公司（以下简称"中船特气"或"公司"）第二届监事会第五次会议 （以下简称"本次会议"或"会议"）于2025年7月31日在公司会议室以现场与通讯相结合的方式召开。本 次会议通知于2025年7月28日通过邮件的方式送达各位监事。本次会议应出席监事3人，实际出席监事3 人。会议由监事会主席李军先生主持，公司部分高管列席会议。会议召集、召开程序符合有关法律、法 规、规章和《公司章程》的规定，会议决议合法、有效。 二、监事会会议审议情况 （一）审议通过《关于提请审议取消监事会、修订〈公司章程〉并办理变更工商登记暨修订部分公司治 理制度的议案》 1.审议通过《关于提请审议取消监事会、修订〈公司章程〉并办理变更工商登记的议案》 为贯彻落实《中华人 ...

关于取消监事会、修订《公司章程》及部分公司治理制度的公告 证券代码：688146 证券简称：中船特气 公告编号：2025-040 中船（邯郸）派瑞特种气体股份有限公司 中船（邯郸）派瑞特种气体股份有限公司（以下简称"公司"）于 2025 年 7 月 31 日召开第二届董事会第五次会议，审议通过了《关于提请审议取消监事会、 修订 <公司章程> 并办理变更工商登记暨修订部分公司治理制度的议案》。该议案部 分事项尚需提交公司股东会审议，现将相关事项公告如下： 一、 取消监事会的情况 为贯彻落实《中华人民共和国公司法》（以下简称："《公司法》"）和中国证监 会《上市公司章程指引》 《关于新 <公司法> 配套制度规则实施相关过渡期安排》 《上 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 海证券交易所科创板股票上市规则》等相关法律法规、规范性文件的规定，进一步 完善公司法人治理结构、提升公司规范运作水平，公司拟取消监事会，监事会职权 由董事会审计委员会行使，《监事会议事规则》予以废止。上述事项尚需提交公司 股东会审议。 在公司股东 ...